Pfizer Asks FDA to Approve Their Covid-19 Vaccine for Children Aged 5 to 11

Pfizer Asks FDA to Approve Their Covid-19 Vaccine for Children Aged 5 to 11


Pfizer and BioNTech asked the Food and Drug Administration on Thursday to approve their controversial COVID-19 vaccine for children aged 5-11.

The New York Times reports that “the agency has promised to move quickly on the request and has tentatively scheduled a meeting on Oct. 26 to consider it. A ruling is expected between Halloween and Thanksgiving.”

“With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against Covid-19,” Pfizer said in a statement on Thursday.

Trending: REPORT: Vaccinated Delta Pilot Dies Mid-Flight, Plane Makes Emergency Landing

The Times report continues, “Pfizer has proposed giving children one-third of the adult dosage. That might require adding more diluent to each injection or using a different vial or syringe. The company was

Continue reading

You Might Like

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend